These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 411899)
1. Clinical and endocrinological evaluation of 16 acromegalic patients treated by transsphenoidal surgery. Leavens ME; Samaan NA; Jesse RH; Byers RM J Neurosurg; 1977 Dec; 47(6):853-60. PubMed ID: 411899 [TBL] [Abstract][Full Text] [Related]
2. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly. Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847 [TBL] [Abstract][Full Text] [Related]
4. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas. Chang CC; Chen FW; Hsieh HC Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734 [TBL] [Abstract][Full Text] [Related]
5. [Stimulation of growth hormone and prolactin secretion with TRH in acromegaly (author's transl)]. von Werder K; Fahlbusch R; Gay R; Pickhardt CR; Schultz B Klin Wochenschr; 1976 Apr; 54(7):335-8. PubMed ID: 177804 [TBL] [Abstract][Full Text] [Related]
7. Neurosurgical management of acromegaly. Results in 82 patients treated between 1972 and 1977. Laws ER; Piepgras DG; Randall RV; Abboud CF J Neurosurg; 1979 Apr; 50(4):454-61. PubMed ID: 423000 [TBL] [Abstract][Full Text] [Related]
8. Mixed TSH- and HGH-secreting pituitary adenoma. Coculescu M; Pop A; Constantinovici A; Oprescu M; Temeli E; Marinescu I Endocrinologie; 1982; 20(3):209-16. PubMed ID: 7146814 [TBL] [Abstract][Full Text] [Related]
9. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells. Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960 [TBL] [Abstract][Full Text] [Related]
10. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly. Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226 [TBL] [Abstract][Full Text] [Related]
12. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly. Ishibashi M; Yamaji T J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426 [TBL] [Abstract][Full Text] [Related]
13. Prolactin secretion in acromegalic patients before and after selective adenomectomy. Tsuchiya H; Onishi T; Takamoto S; Imanaka S; Saitoh Y; Mogami H; Mori S; Uozumi T; Kumahara Y J Clin Endocrinol Metab; 1985 Jul; 61(1):104-9. PubMed ID: 3923026 [TBL] [Abstract][Full Text] [Related]
14. Evidence for the release of a novel pituitary polypeptide (7B2) from the growth hormone-producing pituitary adenoma of patients with acromegaly. Natori S; Iguchi H; Nawata H; Kato K; Ibayashi H; Nakagaki H; Chrétien M J Clin Endocrinol Metab; 1988 Feb; 66(2):430-7. PubMed ID: 3123513 [TBL] [Abstract][Full Text] [Related]
15. Early postoperative basal serum GH level and the GH response to TRH in relation to the long-term outcome of surgical treatment for acromegaly: a report on 39 patients. Valdemarsson S; Bramnert M; Cronquist S; Elner A; Eneroth CM; Hedner P; Lindvall-Axelsson M; Nordström CH; Strömblad LG J Intern Med; 1991 Jul; 230(1):49-54. PubMed ID: 1906090 [TBL] [Abstract][Full Text] [Related]
16. Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma. Sanno N; Teramoto A; Osamura RY J Neurosurg; 2000 Aug; 93(2):194-200. PubMed ID: 10930003 [TBL] [Abstract][Full Text] [Related]
17. Early post-operative growth hormone levels predict the result of transsphenoidal tumour removal in acromegaly. Bynke O; Karlberg BE; Kågedal B; Nilsson OR Acta Endocrinol (Copenh); 1983 Jun; 103(2):158-62. PubMed ID: 6858550 [TBL] [Abstract][Full Text] [Related]
18. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas. Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021 [TBL] [Abstract][Full Text] [Related]
19. [Transsphenoidal surgery for a case of empty sella syndrome associated with GH secreting pituitary adenoma]. Aihara H; Tamaki N; Ueyama T; Ishihara Y; Kondoh T No Shinkei Geka; 1996 Dec; 24(12):1119-23. PubMed ID: 8974095 [TBL] [Abstract][Full Text] [Related]
20. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]